Oncolytics Biotech (ONCY) Return on Assets (2009 - 2025)

Oncolytics Biotech (ONCY) has 17 years of Return on Assets data on file, last reported at 0.02% in Q4 2025.

• On a quarterly basis, Return on Assets fell 1.0% year-over-year to 0.02% in Q4 2025; TTM through Dec 2025 was 0.02%, a 1.0% decrease from a year earlier, with the FY2025 full-year figure at 0.03%, down 2.0% from the prior year.
• Return on Assets for Q4 2025 stood at 0.02%, roughly flat from 0.02% in the prior quarter.
• Over the last five years, Return on Assets for ONCY reached as high as 0.01% in Q3 2021 and fell as low as 0.02% in Q2 2023.
• Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2022.
• Across the five-year window, Return on Assets slipped 2 bps in 2022 and grew 2 bps in 2024, its largest moves.
• Year by year, Return on Assets stood at 0.01% in 2021, then slumped by 52 bps to 0.01% in 2022, then jumped by 85 bps to 0.0% in 2023, then sank by 500 bps to 0.01% in 2024, then plunged by 52 bps to 0.02% in 2025.
• Per Business Quant data, the three most recent Return on Assets figures were 0.02% in Q4 2025, 0.02% in Q3 2025, and 0.01% in Q2 2025.